Vitamin K directly antagonizes warfarin. Consistency of intake, not avoidance, is the right clinical approach.
What's happening
Warfarin works by blocking vitamin K epoxide reductase, preventing regeneration of reduced vitamin K needed to activate clotting factors II, VII, IX, and X. Adding exogenous vitamin K — dietary or supplemental — provides the substrate warfarin is trying to keep unavailable. This is a direct antagonism. However, the 2016 systematic review (Violi et al) concluded the clinical implication is often misstated. A key RCT (Sconce et al, N=70 warfarin patients with unstable INR control) showed that low-dose daily vitamin K supplementation (150 micrograms) actually STABILIZED INR in previously unstable patients. Prospective dietary tracking shows an inverse correlation between vitamin K intake variability and INR variability (r = -0.600, p<0.01). Consistency of intake matters more than absolute level. The old 'avoid leafy greens on warfarin' advice is outdated. One cup cooked spinach contains ~900 micrograms of K1 — enough to shift INR if added acutely to a low baseline. Patients with chronically unstable INR may benefit from consistent low-dose K supplementation rather than restriction. Vitamin K2 (MK-4, MK-7) supplements also interact. Patients on DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) do NOT have this interaction — DOACs are not vitamin K antagonists.
Recommendation
Do not change your vitamin K intake — dietary or supplemental — without telling your anticoagulation clinic. Aim for consistent daily intake rather than restriction. Starting a K2 supplement? Ask for an INR check 1-2 weeks after. If your INR is chronically unstable, ask whether a small consistent K supplement might help. If you're on a DOAC, this interaction does not apply.
Timing
Timing within the day does not materially help. The interaction is on the vitamin K cycle at the liver. Consistency day-to-day is what matters.
Sources
— PMID:26962786 — Violi F et al. Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True? A Systematic Review. Medicine (Baltimore) 2016.
— PMID:17690342 — Sconce E et al. Effect of low-dose vitamin K supplementation on INR stability. 2007.
Warfarin works by blocking vitamin K epoxide reductase, preventing regeneration of reduced vitamin K needed to activate clotting factors II, VII, IX, and X. Exogenous vitamin K — dietary or supplemental — provides the substrate warfarin is trying to keep unavailable. The antagonism is real; what's changed is the clinical implication. Contemporary evidence shows consistency of intake matters more than absolute level, and low-dose K supplementation (150 microgram/day) can stabilize unstable INR.
Who should be careful
Newly-initiated warfarin patients — do not dramatically change diet at start; inform the anticoagulation clinic of typical intake.
Patients with chronically unstable INR — may benefit from consistent low-dose K supplementation rather than restriction.
Patients adding vitamin K2 (MK-7) for bone/cardiovascular reasons — this does interact; tell your prescriber.
Patients on DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) — no vitamin K interaction. DOACs do not depend on vitamin K antagonism.
What we don't know
The quantitative relationship between dose change and INR shift is patient-specific; no universal formula applies. The specific comparability of K1 vs K2 (MK-4 vs MK-7) for warfarin interaction strength is not fully characterized.
Why this severity
WARNING, not DANGER: the mechanism is real, but INR monitoring + dose adjustment reliably mitigates. The old 'avoid all greens' advice is outdated. Consistent intake + communication with the anticoagulation clinic is the correct framing.
Evidence quality (GRADE): moderate
Frequently Asked Questions
Can I take vitamin k and warfarin together?
Vitamin K directly antagonizes warfarin. Consistency of intake, not avoidance, is the right clinical approach.. Do not change your vitamin K intake — dietary or supplemental — without telling your anticoagulation clinic. Aim for consistent daily intake rather than restriction. Starting a K2 supplement? Ask for an INR check 1-2 weeks after. If your INR is chronically unstable, ask whether a small consistent K supplement might help. If you're on a DOAC, this interaction does not apply.
How should I time vitamin k and warfarin?
Timing within the day does not materially help. The interaction is on the vitamin K cycle at the liver. Consistency day-to-day is what matters.
Is this interaction dangerous?
This interaction is rated “Warning” by Formulate. Warfarin works by blocking vitamin K epoxide reductase, preventing regeneration of reduced vitamin K needed to activate clotting factors II, VII, IX, and X. Adding exogenous vitamin K — dietary or supplemental — provides the substrate warfarin is trying to keep unavailable. This is a direct antagonism. However, the 2016 systematic review (Violi et al) concluded the clinical implication is often misstated. A key RCT (Sconce et al, N=70 warfarin patients with unstable INR control) showed that low-dose daily vitamin K supplementation (150 micrograms) actually STABILIZED INR in previously unstable patients. Prospective dietary tracking shows an inverse correlation between vitamin K intake variability and INR variability (r = -0.600, p<0.01). Consistency of intake matters more than absolute level. The old 'avoid leafy greens on warfarin' advice is outdated. One cup cooked spinach contains ~900 micrograms of K1 — enough to shift INR if added acutely to a low baseline. Patients with chronically unstable INR may benefit from consistent low-dose K supplementation rather than restriction. Vitamin K2 (MK-4, MK-7) supplements also interact. Patients on DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) do NOT have this interaction — DOACs are not vitamin K antagonists.
The free checker lets you add any combination of supplements and medications at once. The free web app goes further — every stack change surfaces interaction alerts automatically.